no statement of use filed
3545 Cray Court
San Diego
CA
92121
88409002 filed on 30th Apr 2019
Registration Number
N/A
Correspondent Address
Eric R. Moran
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors
No 88409002
No Service Mark
No MBHB 19-953
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
04th Dec 2023 | ABANDONMENT - NO USE STATEMENT FILED |
04th Dec 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
06th May 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
05th May 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
05th May 2023 | SOU EXTENSION 5 GRANTED |
02th May 2023 | SOU TEAS EXTENSION RECEIVED |
02th May 2023 | SOU EXTENSION 5 FILED |
03rd Nov 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
01st Nov 2022 | SOU TEAS EXTENSION RECEIVED |
01st Nov 2022 | SOU EXTENSION 4 FILED |